Dr. Modiano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3945 E Paradise Falls Dr
Ste 105
Tucson, AZ 85712Phone+1 520-689-7030Fax+1 520-395-9796
Education & Training
- University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 1987 - 1989
- Aurora Health CareResidency, Internal Medicine, 1984 - 1987
- Universidad Nacional Autonoma de MexicoClass of 1981
Certifications & Licensure
- AZ State Medical License 1987 - 2025
- WI State Medical License 1985 - 2011
Awards, Honors, & Recognition
- Past President The Arizona Clinical Oncology Society
- Certificate of Merit United States Surgeon General, 1991
- Outstanding Fellow University of Arizona Cancer Center, 1988
- Join now to see all
Clinical Trials
- E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma Start of enrollment: 2011 Jul 19
- Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant Start of enrollment: 2011 Apr 20
- E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2011 Sep 19
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsFilanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma.Darren Pan, Jonathan L Kaufman, Myo Htut, Manish Agrawal, Amitabha Mazumder
Cancer Medicine. 2022-01-01 - 50 citationsPSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in ope...Daniel P. Petrylak, Nicholas J. Vogelzang, Kamal Chatta, Mark D. Fleming, David Smith
The Prostate. 2020-01-01 - 31 citationsRandomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung CancerLecia V. Sequist, Jhanelle E. Gray, Wael A. Harb, Ariel Lopez-Chavez, Robert C. Doebele
The Oncologist. 2019-08-01
Research History
- Principal Investigator1989 - 2015
Professional Memberships
- Member
- Member
Other Languages
- French, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: